Andelyn Biosciences
Andelyn Biosciences to Develop and Manufacture AAV Gene Therapy for Celliaz to Treat Retinitis Pigmentosa
Celliaz will leverage Andelyn's Curator® Suspension Platform for AAV2 vector and plasmid manufacturing to support IND-enabling studies and a planned…